FDA approves GSK RSV vaccine for adults ages 50 to 59

A view shows the headquarters of GlaxoSmithKline in London, Britain, on January 17, 2022. Hannah Mckay | Reuters The Food…

Moderna says FDA approval of RSV vaccine delayed until late May

Nikos Pekiaridis | Light rocket | fake images modern On Friday it said the Food and Drug Administration delayed approval…

Pfizer RSV vaccine protects older adults for two seasons

Respiratory syncytial virus vial. Manjurul | Stock | fake images PfizerThe respiratory syncytial virus vaccine maintained protection in older adults…